Abstract
1. The pharmacokinetics of rac-primaquine (45 mg base) and its principal plasma metabolite, carboxyprimaquine have been investigated in healthy Thai adults prior to and following a single oral dose of mefloquine (10 mg kg-1). 2. Primaquine was rapidly absorbed, attaining peak plasma concentrations (median and range) of 167 (113-532) micrograms l-1 in 2 (1-4) h. Thereafter, concentrations declined rapidly with an apparent terminal half-life of 6.1 (1.7-16.1) h and an oral clearance (CLpo) of 33.1 (17.6-49.3) l h-1. Administration of mefloquine had no effect on the values of any of these parameters at the 5% level of significance [Cmax 229 (114-503) micrograms l-1; tmax 3 (2-4) h; t1/2,z 3.9 (1.7-13.5) h; CLpo 34.0 (21.7-49.0) l h-1]. 3. The carboxylic acid metabolite of primaquine achieved maximum concentrations (median and range) of 890 (553-3634) micrograms l-1 at 6 (3-16) h. Thereafter, plasma concentrations of carboxyprimaquine declined to 346 (99-918) micrograms l-1 at 24 h. AUC (0,24 h) was 12737 (6837-27388) micrograms l-1 h. Administration of mefloquine had no effect on the plasma concentrations of this metabolite [Cmax 1035 (174-3015) micrograms l-1; tmax 8 (2-24) h; AUC(0,24) 13471 (2132-17863) micrograms l-1 h]. 4. Th...Continue Reading
References
Aug 4, 1992·Biochemical Pharmacology·K N BangchangD J Back
Sep 1, 1991·British Journal of Clinical Pharmacology·S M MansorG Edwards
Jun 1, 1990·The Journal of Pharmacy and Pharmacology·S M MansorA M Breckenridge
Nov 1, 1989·Transactions of the Royal Society of Tropical Medicine and Hygiene·N J White, S Krishna
Jan 1, 1986·European Journal of Clinical Pharmacology·S C BhatiaR S Satoskar
Oct 15, 1987·Biochemical Pharmacology·D D NichollA M Breckenridge
Feb 15, 1985·Biochemical Pharmacology·J H Riviere, D J Back
Feb 1, 1985·Biochemical Pharmacology·G W MihalyA M Breckenridge
Jun 1, 1985·British Journal of Clinical Pharmacology·G W MihalyA M Breckenridge
Jun 1, 1985·British Journal of Clinical Pharmacology·S A WardA M Breckenridge
Nov 1, 1984·Molecular and Biochemical Parasitology·A P AlvaresM R Hollingdale
Oct 15, 1984·Biochemical Pharmacology·M Murray
Apr 1, 1984·British Journal of Clinical Pharmacology·G W MihalyA M Breckenridge
Oct 1, 1982·The American Journal of Medicine·N J WhiteT Harinasuta
Citations
Jun 26, 2001·European Journal of Drug Metabolism and Pharmacokinetics·K Na-BangchangS Saenglertsilapachai
Mar 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·K N BangchangJ Karbwang
Dec 15, 2012·Malaria Journal·Nicholas J WhiteLucio Luzzatto
Jul 4, 2001·Clinical Pharmacokinetics·P T Giao, P J de Vries
Dec 7, 2011·The American Journal of Tropical Medicine and Hygiene·Hla Y MyintColin Ohrt
Jan 1, 1994·Drug Metabolism Reviews·M S Benedetti, P Dostert
May 3, 2011·FEBS Letters·Ines PetersenMichael Lanzer
Dec 14, 2011·Journal of Pharmaceutical Sciences·Anita NairJennifer B Dressman
Nov 28, 2012·The Lancet Infectious Diseases·Nicholas J White
Apr 9, 2008·Médecine et maladies infectieuses·M OliverS Picot
Sep 6, 2005·Biochemical Pharmacology·Patrick G BrayLeann Tilley
Apr 19, 2015·BMC Infectious Diseases·Jaline GerardinEdward A Wenger
Nov 12, 2014·Antimicrobial Agents and Chemotherapy·Podjanee JittamalaJoel Tarning
Sep 14, 2016·Malaria Journal·Pius S FasinuLarry A Walker
Oct 28, 2016·BMC Medicine·Rithea LeangWalter Robert John Taylor
Apr 2, 2014·Antimicrobial Agents and Chemotherapy·Sasithon PukrittayakameeNicholas J White
Nov 6, 2013·Antimicrobial Agents and Chemotherapy·Brioni R MooreInoni Betuela
Nov 1, 2018·Revista Do Instituto De Medicina Tropical De São Paulo·Amanda Gabryelle Nunes Cardoso MelloJosé Luiz Fernandes Vieira
Nov 30, 2019·Journal of Travel Medicine·Jelena LewisJeff Goad
Jul 9, 2020·Parasitology Research·J O AdebayoS O Malomo
Aug 18, 2016·Expert Review of Anti-infective Therapy·Cindy S Chu, Nicholas J White
Feb 1, 2019·Malaria Journal·Pius S FasinuLarry A Walker
Jan 6, 2021·Current Drug Metabolism·Ana C A X De-Oliveira, Francisco J R Paumgartten